1Srivastava A. Delivery system for gene therapy : adeno-associated virus 2 [J]. Stem Cell Biol Gene Ther,1998,257-285.
2Joseph E, Rabinowitz, Samulski RJ. Building a better vector: the manipulation of AAV virions[J]. Virology,2000,278:301-308.
3Gao GP, Lu FM, Sanmiguel JC,et al. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap[J]. Mol Ther, 2002, 5(5):644-649.
4Zhang HG,Wang YM,Xie JF,et al. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high titer recombinant adeno-associated virus[J]. Gene Ther, 2001,8:704-712.
5Cao L,Liu YH,During MJ,et al. High-titer,wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids[J]. J Virol,2000,74(24) :11456-11463.
6Collaco RF, Cao X, Trempe JP. A helper virus-free packaging system for recombinant adeno-associated virus vectors [ J ]. Gene,1999 ,1 ;238(2) :397-405.
7Auricchio A, Hildinger M,O' connor E,et al. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column[ J]. Hum Gene Ther,2001 , 12:71-76.
8Sun LW, Li J, Xiao X . Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization[ J]. Nat Med,2000,6 ( 5 ): 599-602.
9Chao H, Sun L, Bruce A, et al. Expression of Human Factor Ⅷ by Splicing between Dimerized AAV Vectors [J]. Mol Ther 2002 Jun,5(6) :716-722.
10Halbert CL, Allen JM, Miller AD. Adeno-associated virous type 6(AAV6) vectors mediate efficient transduct airway epithelial cells in mouse lungs compared to that of AAV2 vectors [ J ]. J Virol,2001,75(14) :6615-6624.
